Traduction de «traitement non toléré » (Français → Anglais) :

Definition: This block contains a wide variety of disorders that differ in severity and clinical form but that are all attributable to the use of one or more psychoactive substances, which may or may not have been medically prescribed. The third character of the code identifies the substance involved, and the fourth character specifies the clinical state. The codes should be used, as required, for each substance specified, but it should be noted that not all fourth character codes are applicable to all substances. Identification of the psychoactive substance should be based on as many sources of information as possible. These include self-report data, analysis of blood and other body fluids, characteristic physical and psychological symptom ...[+++]s, clinical signs and behaviour, and other evidence such as a drug being in the patient's possession or reports from informed third parties. Many drug users take more than one type of psychoactive substance. The main diagnosis should be classified, whenever possible, according to the substance or class of substances that has caused or contributed most to the presenting clinical syndrome. Other diagnoses should be coded when other psychoactive substances have been taken in intoxicating amounts (common fourth character .0) or to the extent of causing harm (common fourth character .1), dependence (common fourth character .2) or other disorders (common fourth character .3-.9). Only in cases in which patterns of psychoactive substance-taking are chaotic and indiscriminate, or in which the contributions of different psychoactive substances are inextricably mixed, should the diagnosis of disorders resulting from multiple drug use (F19.-) be used. | Modifiers The following fourth-character subdivisions are for use with categories F10-F19: Code Title .0 Acute intoxication A condition that follows the administration of a psychoactive substance resulting in disturbances in level of consciousness, cognition, perception, affect or behaviour, o ...

Thiazide not tolerated

Definition: A syndrome that occurs following head trauma (usually sufficiently severe to result in loss of consciousness) and includes a number of disparate symptoms such as headache, dizziness, fatigue, irritability, difficulty in concentration and performing mental tasks, impairment of memory, insomnia, and reduced tolerance to stress, emotional excitement, or alcohol. | Postcontusional syndrome (encephalopathy) Post-traumatic brain syndrome, nonpsychotic

Selective oestrogen receptor modulator not tolerated

Bisphosphonates not tolerated

Angiotensin II receptor antagonist not tolerated

Noncompliance with medication regimen

Does not comply with treatment

Guayule-latex examination/treatment glove, non-powdered

Not only are there treatment related concerns, such as a decreased ability to adhere to or tolerate the adverse effects of the antiviral therapy, but also there is a risk of progressive liver disease from continued alcohol use or re-infection with hepatitis C following treatment through continued unsafe needle use [60-63].

Targeted Approach Represents Paradigm Shift In The Diagnosis And Treatment Of Non-Small Cell Lung Cancer (NSCLC) With a recent Health Canada approval for IRESSA®, Canadian lung cancer patients can now be tested for EGFR mutation status and be treated with a more effective and better tolerated alternative to chemotherapy, as a first-line therapy

Indication for use of IV antimalarial therapy (Check all that apply): Continued vomiting or unable to tolerate oral therapy (Note: if this is the only indication for IV therapy, then QUININE preferred) Impaired consciousness or coma Abnormal bleeding/DIC Severe anemia (Hb ≤50 g/L) Hemoglobinuria (macroscopic) Renal failure (Cr > 265µmol/L or > upper limit for age for children Pulmonary edema/ARDS/respiratory failure Hypoglycemia (< 2.2mmol/L) Parasitemia (≥2% in non-immune, ≥5% in semi-immune) Acidemia/acidosis (pH< 7.25, HCO< 15mmol/L or venous lacate> 5mmol/L) Repeated generalized convulsions (≥3 in 24hrs) Circulatory collapse/shock (S ...[+++]BP< 80mmHg + cold extremities Jaundice (Total bilirubin > 45µmol/L) Other (specify):

Such drugs would increase the treatment choices for oral therapy of Falciparum malaria in Canada, where atovaquone/ proguanil (Malarone) is frequently used for chemoprophylaxis (and hence may be disqualified as a therapeutic choice), and the only other treatment choice, quinine in combination with a tetracycline, is often poorly tolerated.